Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
Authors
Keywords
-
Journal
Science Advances
Volume 3, Issue 8, Pages e1701102
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-08-31
DOI
10.1126/sciadv.1701102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
- (2017) Keertan Dheda et al. Lancet Respiratory Medicine
- Delamanid and Bedaquiline Resistance inMycobacterium tuberculosisAncestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee
- (2016) Harald Hoffmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients
- (2016) John S. Bradley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China
- (2016) Xubin Zheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
- (2016) Devyani Deshpande et al. CLINICAL INFECTIOUS DISEASES
- Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
- (2016) Devyani Deshpande et al. CLINICAL INFECTIOUS DISEASES
- Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
- (2016) Devyani Deshpande et al. CLINICAL INFECTIOUS DISEASES
- Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
- (2016) Soumya Swaminathan et al. CLINICAL INFECTIOUS DISEASES
- Repurposing clinically approved cephalosporins for tuberculosis therapy
- (2016) Santiago Ramón-García et al. Scientific Reports
- Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
- (2015) Chawangwa Modongo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Avibactam Alone and in Combination with Ceftazidime in Healthy Male Volunteers: Results of Two Randomized, Placebo-Controlled Studies
- (2015) Henri Merdjan et al. CLINICAL DRUG INVESTIGATION
- The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens
- (2015) Dakshina Chilukuri et al. CLINICAL INFECTIOUS DISEASES
- Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience
- (2015) Marco Cavaleri et al. CLINICAL INFECTIOUS DISEASES
- Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens
- (2015) David P. Nicolau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
- (2015) Guido V. Bloemberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
- (2014) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Redefining Multidrug-Resistant Tuberculosis Based on Clinical Response to Combination Therapy
- (2014) Tawanda Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The pyrazinamide susceptibility breakpoint above which combination therapy fails
- (2014) T. Gumbo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
- (2014) Keertan Dheda et al. Lancet Respiratory Medicine
- Thioridazine Pharmacokinetic-Pharmacodynamic Parameters “Wobble” during Treatment of Tuberculosis: a Theoretical Basis for Shorter-Duration Curative Monotherapy with Congeners
- (2013) Sandirai Musuka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Hearing loss in children treated for multidrug-resistant tuberculosis
- (2012) James A. Seddon et al. JOURNAL OF INFECTION
- New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
- (2010) T. Gumbo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction and Modulation of Two Antagonistic Cell Wall Enzymes of Mycobacteria
- (2010) Erik C. Hett et al. PLoS Pathogens
- Continuous versus Intermittent Infusions of Ceftazidime for Treating Exacerbation of Cystic Fibrosis
- (2009) D. Hubert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
- (2009) Seok-Yong Eum et al. CHEST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search